Recent Press Releases

CROWN BIOSCIENCE ACQUIRES MOLECULAR RESPONSE'S PATIENT DERIVED XENOGRAFT (PDX) BUSINESS

SANTA CLARA, CA (12TH FEBRUARY 2015) – CROWN BIOSCIENCE, INC., A LEADING GLOBAL DRUG DISCOVERY AND DEVELOPMENT SERVICE COMPANY HAS ANNOUNCED THE ACQUISITION OF MOLECULAR RESPONSE'S PDX...

Evotec Adopts ChemAxon's Compliance Checker to Aid Controlled Substance Management

ChemAxon and Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced the licensing and deployment of ChemAxon's Compliance Checker technology and content package to...

SIRO Clinpharm Announces Relocation of Corporate Offices

SIRO Clinpharm, an award-winning Clinical Research Organization (CRO), announced relocation of its corporate headquarters withinMumbai, India, with effect from February 11, 2015. This move allows...

Catalent Reports Second Quarter Fiscal Year 2015 Results

SOMERSET, N.J.--(BUSINESS WIRE)-- Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health...

Actavis to Divest Pharmatech to TPG

DUBLIN and FORT WORTH, Texas -- Actavis plc (NYSE: ACT) and TPG, the global private investment firm, today announced that they have entered into definitive agreements, under which Actavis will divest...

AMRI Announces Fourth Quarter and Full Year 2014 Results

ALBANY, N.Y., Feb. 12, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the fourth quarter and full year ended December 31, 2014. "While our OsoBio...

inVentiv Health To Open New Clinic In Miami, Florida

Focusing On Patient Access and Recruitment, Site Will Expand inVentiv Health's Phase I Clinical Services to U.S. Princeton, NJ – inVentiv Health, a global provider of best-in-class clinical...

Charles River Laboratories Announces Fourth-Quarter and Full-Year 2014 Results from Continuing Operations and Provides 2015 Guidance

Charles River Laboratories Announces Fourth-Quarter and Full-Year 2014 Results from Continuing Operations and Provides 2015 Guidance Print Friendly – Fourth-Quarter Revenue of $329.5...

WuXiPRA Appoints Two Key Executives

SHANGHAI -- WuXiPRA, a leading clinical services company with operations in the greater China region, today announced appointments of two key executives. Liedong Xu was named Executive Vice President...

Medidata Teams Up with Garmin to Optimize Clinical Trials through Mobile Health Technology

vívofit Activity Tracker Integrated with Medidata Clinical Cloud to Enable Enhanced Patient Engagement, Data Quality and Operational Efficiencies in Clinical Trials NEW YORK, N.Y. –...

BioClinica Announces Record eClinical Growth in 2014

NEWTOWN, Pa. -- BioClinica®, Inc., a specialty clinical trials services and technology provider, today announced that 2014 was a record year for its eClinical technologies business unit, with...

Quintiles Continues Governance Transition Plan

RESEARCH TRIANGLE PARK, N.C.--Quintiles Transnational Holdings Inc. ("Quintiles" or the "Company") (NYSE:Q) announced today that its Board and principal shareholders have reached...

TrialReach Raises $13.5M Series B Led by Smedvig Capital

Funding will fuel TrialReach's clinical trial platform growth and expansion into the U.S. LONDON -- TrialReach, the world's largest provider of clinical trial information, today announced it...

TransCelerate BioPharma Welcomes Merck & Co. and Novo Nordisk to its Membership Roster

PHILADELPHIA--TransCelerate BioPharma Inc. today announced two new members, Merck & Co. Inc., and Novo Nordisk, to the biopharmaceutical non-profit organization. In addition, TransCelerate has...

Campbell Alliance's New Suite Of Services Delivers Launch Excellence To Clients

The Launch Suite Builds on Pioneering Model That Has Delivered an Average of 45 Percent Improvement in Time to Market for Clients NEW YORK – Campbell Alliance, the consulting arm of inVentiv...

Astellas Broadens Commitment to Clinical Trial Data Transparency

TOKYO, Feb. 2, 2015 -- Astellas Pharma Inc. (Tokyo: 4503, "Astellas") announced today that the company will now make trial data available throughwww.clinicalstudydatarequest.com, an...

genae Buys e-novex

ANTWERP, Belgium -- genae, a global Contract Research Organization (CRO) and services provider for the medical industries, announced today the acquisition of e-novex, a leading provider of electronic...

ICON Creates New Global Innovation Hub in Ireland to Advance Clinical Development

Global Innovation Hub will create 200 Scientific, IT and Business jobs in Ireland Dublin, Ireland – ICON plc, (NASDAQ: ICLR) a global provider of outsourced development services to the...

Catalent Expands Integrated Softgel Operations Through Coating & Packaging Investment In Eberbach, Germany

Somerset, N.J. — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today...

Paragon Announces Management Team Additions

BALTIMORE -- Paragon Bioservices, Inc., a contract research and GMP manufacturing organization with a focus on the development and manufacturing of biopharmaceuticals, today has announced the...